HEPTA Medical Secures €5.7 Million Series A, Led by BPI France to Advance Minimally Invasive Lung Cancer Treatment
/
DateSep 04 2024
Founded in 2019 by Sofinnova’s medtech acceleration team, MD Start The funds will be used for the 510(k) regulatory approval process for the first version... Read More →